US 11020485
Pharmaceutical formulation
granted A61KA61K31/573A61K31/661
Quick answer
US patent 11020485 (Pharmaceutical formulation) held by Semnur Pharmaceuticals, Inc. expires Mon May 27 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Semnur Pharmaceuticals, Inc.
- Grant date
- Tue Jun 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 27 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/573, A61K31/661, A61K45/06, A61K47/02